MSB's Potential Partner, page-2

@madamswer

On behalf of all MSB followers, thank you for providing the link to this video. Whether they admit it or not, without your post, most of us will probably miss this interview.

Even if Chanos is only half right about his assessment of MNK, this company doesn't look like the part of a white knight that MSB has been desperately looking for.

For MSB whose existential purpose is to find cure for various illness and do good for humanity, does it really want to be associated with MNK that is now forever tainted with its dodgy business practices, such as inflating price of Achtar from $40 to $35,000 over a number of years?

Personally, I find it extremely contradictory if a MSB supporter attacks another poster's morality simply because that poster has a different view of MSB and at the same time, continue to support MSB management in their negotiation with a partner who has been proven to have some questionable business tactics.

If MNK is indeed not in the position to be MSB's reliable long term partner, then it is back to the square zero for MSB.

Teva is gone.

Two years on Celgene is still holding its pen hovering above the dotted line, probably falling asleep.

MNK is still a possibility. But who knows? They now have less than 4 months to make up their mind.

Next candidate to bankroll MSB?